Sanofi

Sanofi-aventis

Aventis Pharma S.a.

Antonio Ugolini

Eric Bacque

Conception Nemecek

Sylvie Wentzler

Eva Albert

Hans Matter

Michel Tabart

Armin Hofmeister

Baptiste Ronan

Frank Halley

Manfred Schudok

Fabrice Viviani

Catherine Souaille

Kristin Breitschopf

The disclosure relates to compounds of formula (I): wherein, A, W, X, and Ra are as defined in the disclosure, and salts thereof, and to pharmaceutical compositions comprising said compounds, to processes for preparing them, and to their use as medicaments, in particular as MET inhibitors.

6-triazolopyridazine sulfanyl benzothiazole derivatives as MET inhibitors

The disclosure relates to substituted pyrazolo-pyridines, compositions containing them, methods for the production thereof, and to their use as medicaments, in particular, as anticancer agents.

Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use

The present invention is directed to a compound of formula (I), wherein R, R, R, R, A, L and n are as defined herein, its pharmaceutical composition, preparation and uses as a MMP inhibitor.

Substituted tetrahydroisochinolines as MMP inhibitors, related production method and use as medicine

Growing community of inventors

Paris, France

Antonio Ugolini